in this issue
Regions :: Western Europe :: Switzerland
Roche to invest $209 million to build ADC facility
7:16 AM MDT | October 14, 2013 | Deepti Ramesh
Roche (Basel, Switzerland) says it will invest 190 million Swiss francs ($209 million) in the construction of a new production facility at Basel, which will support the manufacturing of antibody-drug conjugate (ADC) medicines. ADCs offer a new treatment method for cancer in which cancer cells are destroyed in a more targeted way, and healthy cells are less affected. The investment at Basel is expected to create 50 jobs. The construction of the new production facility will begin in January 2014; production at the unit will start by August 2016. “The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee